Browsing by Author Malfettone, Andrea
Showing results 1 to 14 of 14
| Issue Date | Title | Author(s) |
|---|---|---|
| 11-Jul-2023 | A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; López Miranda, Elena; Gion, María; Abad Adán, Elena; Alcalá López, Daniel; Pérez Escuredo, Jhudit; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier |
| 1-Jan-2020 | Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer | Caballero Díaz, Daniel; Bertran Rodríguez, Esther; Peñuelas Haro, Irene; Moreno Càceres, Joaquim; Malfettone, Andrea; López Luque, Judit; Addante, Annalisa; Herrera, Blanca; Sánchez, Aránzazu; Alay, Ania; Solé Acha, Xavier; Serrano Piñol, M. Teresa; Ramos Rubio, Emilio; Fabregat Romero, Isabel |
| 1-Nov-2019 | Downregulation of epidermal growth factor receptor in hepatocellular carcinoma facilitates transforming growth factor-β-induced epithelial to amoeboid transition | López Luque, Judit; Bertran Rodríguez, Esther; Crosas Molist, Eva; Maiques, Oscar; Malfettone, Andrea; Caja Puigsubirà, Laia; Serrano Piñol, M. Teresa; Ramos Rubio, Emilio; Sanz Moreno, Victoria; Fabregat Romero, Isabel |
| 24-May-2021 | Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism | Soukupova, Jitka; Malfettone, Andrea; Bertran Rodríguez, Esther; Hernández Álvarez, María Isabel; Peñuelas Haro, Irene; Dituri, Francesco; Giannelli, Gianluigi; Zorzano Olarte, Antonio; Fabregat Romero, Isabel |
| 7-Mar-2018 | Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression | Rani, Bhavna; Malfettone, Andrea; Dituri, Francesco; Soukupova, Jitka; Lupo, Luigi; Mancarella, Serena; Fabregat Romero, Isabel; Giannelli, Gianluigi |
| 2016 | New insights into the crossroads between EMT and stemness in the context of cancer | Fabregat Romero, Isabel; Malfettone, Andrea; Soukupova, Jitka |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertran, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 2014 | Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma | Bhavna, Rani; Cao, Yuan; Malfettone, Andrea; Tomuleasa, Ciprian; Fabregat Romero, Isabel; Giannelli, Gianluigi |
| 2-Oct-2017 | Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism. | Soukupova, Jitka; Malfettone, Andrea; Hyroššová, Petra; Hernández-Alvarez, María Isabel; Peñuelas Haro, Irene; Bertran Rodríguez, Esther; Junza Martínez, Alexandra; Capellades, Jordi; Giannelli, Gianluigi; Yanes, Oscar; Zorzano Olarte, Antonio; Perales Losa, Carlos; Fabregat Romero, Isabel |
| 22-Jun-2021 | The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis” | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez López, Jordi |
| 12-Oct-2017 | The level of caveolin-1 expression determines response to TGF-ß as a tumor suppressor in hepatocellular carcinoma cells | Moreno Càceres, Joaquim; Caballero Díaz, Daniel; Chike Nwosu, Zeribe; Meyer, Christoph; López Luque, Judit; Malfettone, Andrea; Lastra, Raquel; Serrano Piñol, M. Teresa; Ramos Rubio, Emilio; Dooley, Steven; Fabregat Romero, Isabel |
| 1-Sep-2020 | The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez López, Jordi |
| 27-Oct-2022 | Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study | Pérez García, José Manuel, 1944-; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marmé, Frederik; Prat Aparicio, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofía; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio |
| 1-Dec-2020 | Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial | López Miranda, Elena; Pérez García, José Manuel; Cosimo, Serena Di; Brain, Etienne; Ravnik, Maja; Escrivá de Romaní, Santiago; Vidal Losada, Maria Jesús; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart Cussac, Antonio; Suter, Thomas M.; Cortés, Javier |